{"id":"W2534121364","doi":"10.1200/jco.2006.24.18_suppl.13015","title":"A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first line treatment in hormone refractory prostate cancer (HRPC)","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Metal-Catalyzed Oxygenation Mechanisms","field":"Chemistry","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre; BC Cancer Agency","funders":"","keywords":"Docetaxel; Medicine; Neutropenia; Tolerability; Prostate cancer; Internal medicine; Chemotherapy; Oncology; Ribonucleotide reductase; Pharmacology; Cabazitaxel; Cancer; Gastroenterology; Adverse effect; Androgen deprivation therapy; Biology; Protein subunit","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001526705,0.0002373149,0.001410027,0.0001163282,0.0001059747,0.00001427181,0.0002751395,0.0002928499,0.0001581975],"category_scores_gemma":[0.001020988,0.0001524882,0.0002716856,0.0001953727,0.0001815548,0.000142468,0.0001518085,0.0006627439,0.000002996562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003899437,"about_ca_system_score_gemma":0.000986267,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001001411,"about_ca_topic_score_gemma":0.002825445,"domain_scores_codex":[0.9956815,0.0003153751,0.002970218,0.0003071481,0.0004565102,0.0002692274],"domain_scores_gemma":[0.9952215,0.00092047,0.003031532,0.0003649587,0.0002749639,0.0001865537],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.04393334,0.2411731,0.03755182,0.0003416367,0.003349251,0.004568811,0.01037114,0.004597808,0.2589231,0.000295636,0.003514289,0.39138],"study_design_scores_gemma":[0.4646443,0.1673226,0.1346326,0.0007209769,0.003665392,0.001113388,0.004532195,0.003265525,0.07675192,0.003458715,0.1384464,0.001445941],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954352,0.001522504,0.000006309469,0.001490026,0.0003681777,0.0003904304,0.0000427315,0.00000952121,0.000735086],"genre_scores_gemma":[0.9947795,0.002822866,0.000310904,0.0001137268,0.0004730776,0.00002523839,0.00000411956,0.00002703281,0.001443549],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.420711,"threshold_uncertainty_score":0.6218287,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0692760631176686,"score_gpt":0.4176388006762158,"score_spread":0.3483627375585472,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}